Evidence map›Paper›PMID 30467354›Full record

ArticleJournal of human genetics2019

A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy.

Takuya Miyabayashi, Tatsuhiro Ochiai, Naoki Suzuki, Masashi Aoki, Takehiko Inui, Yukimune Okubo, Ryo Sato, Noriko Togashi, Hiroshi Takashima, Hiroyuki Ishiura and 4 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cell type-specific gene therapy confers protection against motor neuron disease caused by a TFG variant.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Article
  4. TFG regulates secretory and endosomal sorting pathways in neurons to promote their activity and maintenance.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Identification of a novel mutation inNeurology. Genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Takuya MiyabayashiDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Tatsuhiro OchiaiDepartment of Pediatric Orthopedic Surgery, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Naoki SuzukiDepartment of Neurology, Tohoku University School of Medicine, Sendai, 980-8574, Japan.ORCID http://orcid.org/0000-0001-8880-8554
Masashi AokiDepartment of Neurology, Tohoku University School of Medicine, Sendai, 980-8574, Japan.
Takehiko InuiDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Yukimune OkuboDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Ryo SatoDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Noriko TogashiDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan.
Hiroshi TakashimaDepartment of Neurology and Geriatrics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, 890-8520, Japan.
Hiroyuki IshiuraDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0003-2975-7309
Shoji TsujiDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0001-5602-5686
Kishin KohDepartment of Neurology, Graduate School of Medical Sciences, University of Yamanashi, Yamanashi, 409-3898, Japan.
Yoshihisa TakiyamaDepartment of Neurology, Graduate School of Medical Sciences, University of Yamanashi, Yamanashi, 409-3898, Japan.
Kazuhiro HaginoyaDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, 989-3126, Japan. khaginoya@kha.biglobe.ne.jp.
Miyagi Children's Hospital · JPThe University of Tokyo · JPTohoku University · JPUniversity of Yamanashi · JPKagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tropomyosin-receptor kinase fused gene (TFG) has recently been implicated in several distinct hereditary disorders, including the autosomal-recessive form of complicated hereditary spastic paraplegia called SPG57. Previously, three homozygous variants of the TFG gene were reported in five families with SPG57, in which early onset spastic paraplegia, optic atrophy, and peripheral neuropathy were variably identified. Here, we present the first Japanese patient with SPG57, and have added a homozygous p.Ile66Thr variant as the fourth SPG57 genotype.

Indexed as

MutationAdultAge of OnsetChild, PreschoolFemaleGenetic Predisposition to DiseaseHomozygoteHumansMaleParaplegiaPedigreePolyneuropathiesProteinsSensorimotor CortexVesicular Transport ProteinsProteinsTFG protein, humanVesicular Transport Proteins

Identifiers

PMID30467354
OpenAlexW2900845705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.